The global pharmacovigilance market is expected to reach $15.9 billion by 2032, driven by technological advancements and increasing patient awareness and reporting. Advanced data processing techniques like big data analytics and NLP are crucial in efficiently mining and analyzing the vast amounts of data collected from various sources.